Skip to content

The clinical effects of Transcatheter arterial chemoembolization in the treatment of medium or late stage primary hepatic carcinoma: protocol for a retrospective clinical observation

The clinical effects of Transcatheter arterial chemoembolization in the treatment of medium or late stage primary hepatic carcinoma: protocol for a retrospective clinical observation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041212
Enrollment
Unknown
Registered
2020-12-22
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hepatic carcinoma

Interventions

Observation group:Transcatheter arterial chemoembolization
Control group :Other surgical procedures except hepatic artery chemoembolization, including local resection, radiofrequency ablation, etc.

Sponsors

Tangshan workers' Hospital of Hebei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with primary liver cancer confirmed by pathological diagnosis or imaging examination; 2. Patients with child Pugh grade A and B of liver function; 3. Patients with less than or equal to 3 tumors had no signs of intrahepatic and extrahepatic metastasis or vascular invasion; 4. Subjects who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant hypertension, serious arrhythmia, acute myocardial infarction, cerebrovascular accident and other serious diseases. 2. Patients with recent acute infection, trauma, surgery, diabetic ketoacidosis, hyperosmolar coma. 3. Patients with severe primary diseases such as brain, liver, kidney and hematopoiesis, psychosis and cognitive dysfunction. 4. Patients with other malignant tumors and other organ failure.

Design outcomes

Primary

MeasureTime frame
Overall efficiency;Overall efficiency;

Countries

China

Contacts

Public ContactHaoliang Zhang

Tangshan workers' Hospital of Hebei Province

keuue0@163.com+86 315-2821821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026